David C. Klonoff

3.5k total citations · 2 hit papers
28 papers, 1.8k citations indexed

About

David C. Klonoff is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, David C. Klonoff has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Genetics. Recurrent topics in David C. Klonoff's work include Diabetes Management and Research (21 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers) and Pancreatic function and diabetes (7 papers). David C. Klonoff is often cited by papers focused on Diabetes Management and Research (21 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers) and Pancreatic function and diabetes (7 papers). David C. Klonoff collaborates with scholars based in United States, Saudi Arabia and France. David C. Klonoff's co-authors include Sultan Ayoub Meo, Javed Akram, Anusha Sultan Meo, Guillermo E. Umpierrez, Ishfaq A. Bukhari, Jennifer Crowe, Jordan Messler, Valerie Garrett, Raymie McFarland and Robby Booth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

David C. Klonoff

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

2020 503 citations Bruce W. Bode, Valerie Garrett et al. Journal of Diabetes Science and Technology profile →
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

2021 404 citations Sultan Ayoub Meo, Ishfaq A. Bukhari et al. PubMed profile →

Peers

Countries citing papers authored by David C. Klonoff

Since Specialization

Citations

This map shows the geographic impact of David C. Klonoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Klonoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Klonoff more than expected).

Fields of papers citing papers by David C. Klonoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Klonoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Klonoff. The network helps show where David C. Klonoff may publish in the future.

Co-authorship network of co-authors of David C. Klonoff

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Klonoff. A scholar is included among the top collaborators of David C. Klonoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Klonoff. David C. Klonoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantifying Environmental Waste From Diabetes Devices in the U.S. 2025 ·Diabetes Care ·(unknown), (unknown), (unknown), (unknown), David C. Klonoff, David Ahn, David Kerr, Anne L. Peters, Athena Philis‐Tsimikas, Viral N. Shah, (unknown), Yijiong Yang, Chengdong Li, Jing Wang	2
2	A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting 2024 ·Diabetes Care ·Mohammed E. Al‐Sofiani, (unknown), (unknown), Naweed Alzaman, David C. Klonoff, Abdullah M. Alguwaihes	11
3	Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes 2023 ·Diabetes Obesity and Metabolism ·Kagan E. Karakus, Viral N. Shah, David C. Klonoff, Halis Kaan Aktürk	8
4	Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia 2021 ·Diabetes Obesity and Metabolism ·Ronald Goldenberg, Vanita R. Aroda, Liana K. Billings, (unknown), Anders Meller Donatsky, Ehsan Parvaresh Rizi, Gracjan Podgorski, Katarı́na Rašlová, David C. Klonoff, Richard M. Bergenstal	18
5	Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics 2021 ·SHILAP Revista de lepidopterología ·Sultan Ayoub Meo, Anusha Sultan Meo, Fawzi Aljassir, David C. Klonoff	81
6	COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. breakdown → 2021 ·PubMed ·Sultan Ayoub Meo, Ishfaq A. Bukhari, Javed Akram, Anusha Sultan Meo, David C. Klonoff	404
7	Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States breakdown → 2020 ·Journal of Diabetes Science and Technology ·Bruce W. Bode, Valerie Garrett, Jordan Messler, Raymie McFarland, Jennifer Crowe, Robby Booth, David C. Klonoff	503
8	Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis 2020 ·Diabetes Care ·David C. Klonoff, Jordan Messler, Guillermo E. Umpierrez, Limin Peng, Robby Booth, Jennifer Crowe, Valerie Garrett, Raymie McFarland, Francisco J. Pasquel	60
9	Hospital Diabetes Meeting 2020 2020 ·Journal of Diabetes Science and Technology ·Guillermo E. Umpierrez, Robert J Rushakoff, Jane Jeffrie Seley, Jennifer Y. Zhang, Trisha Shang, Julia Han, Elias K. Spanakis, (unknown), Andjela Drincic, Kristen Kulasa, Carlos E. Mendez, (unknown), Amisha Wallia, Mihail Zilbermint, David C. Klonoff	12
10	Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. 2020 ·PubMed ·Sultan Ayoub Meo, David C. Klonoff, Javed Akram	140
11	Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes 2019 ·Diabetes Care ·David C. Klonoff, Bruce W. Bode, Nathan Cohen, Marc S. Penn, (unknown), Douglas B. Muchmore	19
12	The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now? 2019 ·Journal of Diabetes Science and Technology ·Julia Han, James H. Nichols, Mark J. Rice, David C. Klonoff	5
13	Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital 2018 ·Diabetes Care ·Guillermo E. Umpierrez, David C. Klonoff	154
14	Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors 2018 ·Diabetes Care ·David C. Klonoff, Joan Lee Parkes, Boris Kovatchev, David Kerr, Wendy C. Bevier, Ronald Brazg, Mark P. Christiansen, Timothy S. Bailey, James H. Nichols, Michael A. Kohn	101
15	A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5) 2018 ·Diabetes Obesity and Metabolism ·David C. Klonoff, Mark L. Evans, Wendy Lane, Hans‐Peter Kempe, Éric Renard, J. Hans DeVries, Tina Graungaard, (unknown), (unknown), Tadej Battelino	57
16	Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital 2018 ·Journal of Diabetes Science and Technology ·Bithika Thompson, Mary T. Korytkowski, David C. Klonoff, Curtiss B. Cook	14
17	Accuracy and Injection Force of the Gla-300 Injection Device Compared With Other Commercialized Disposable Insulin Pens 2015 ·Journal of Diabetes Science and Technology ·David C. Klonoff, (unknown), (unknown), (unknown), Mona Abdel‐Tawab, (unknown), Thomas Haak	9
18	Timely Hospital Glucose Measurement: Here Today, Gone Tomorrow? 2014 ·Mayo Clinic Proceedings ·David C. Klonoff, Robert A. Vigersky, James H. Nichols, Mark J. Rice	5
19	Hyperprolactinemia in a patient with a pituitary and an ovarian dermoid tumor 1990 ·Neurosurgery ·David C. Klonoff, Douglas Kahn, (unknown), Charles B. Wilson	6
20	Macroamylasemia and other immunoglobulin-complexed enzyme disorders. 1980 ·PubMed ·David C. Klonoff	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact